Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 5,812 Shares of Stock

Key Points

• Claritev SVP Tiffani Misencik sold 5,812 shares at an average price of $23.81, totaling $138,383.72. The transaction, executed under a Rule 10b5-1 plan, reduced her ownership by 5.11% to 107,917 shares.
• Claritev shares fell $1.80 to $22.06, well below their 50-day moving average of $31.85. The stock has traded between $11.50 and $73.68 over the past year.
• The company reported quarterly EPS of $1.41, exceeding the consensus estimate of a $4.10 loss, on revenue of $257.48 million. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $44.83.

Claritev (NYSE:CTEV - Get Free Report) SVP Tiffani Misencik sold 5,812 shares of the firm's stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $23.81, for a total value of $138,383.72. Following the completion of the sale, the senior vice president directly owned 107,917 shares of the company's stock, valued at $2,569,503.77. This trade represents a 5.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Tiffani Misencik also recently made the following trade(s):

• On Friday, August 14th, Tiffani Misencik sold 8,850 shares of Claritev stock. The stock was sold at an average price of $40.07, for a total value of $354,619.50.

Claritev Stock Performance

Shares of CTEV stock traded down $1.80 on Friday, hitting $22.06. 188,785 shares of the stock traded hands, compared to its average volume of 162,567. The firm's 50-day moving average price is $31.85 and its two-hundred day moving average price is $27.59. The stock has a market capitalization of $373.92 million, a PE ratio of -1.30 and a beta of 0.93. Claritev has a twelve month low of $11.50 and a twelve month high of $73.68.

Claritev (NYSE:CTEV - Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.10) by $5.51. The firm had revenue of $257.48 million for the quarter. On average, equities research analysts anticipate that Claritev will post -15.13 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Wall Street Zen upgraded Claritev from a "sell" rating to a "hold" rating in a research report on Saturday, August 8th. Zacks Research upgraded Claritev from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 13th. Citigroup reaffirmed a "buy" rating and issued a $45.00 price target (up from $40.00) on shares of Claritev in a research note on Monday, August 10th. Piper Sandler reiterated an "overweight" rating and set a $73.00 price target on shares of Claritev in a report on Wednesday, August 12th. Finally, Barclays reiterated an "overweight" rating and set a $40.00 price target (up from $28.00) on shares of Claritev in a report on Thursday, August 20th. Six equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $44.83.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Arini Captial Management Ltd acquired a new stake in shares of Claritev in the fourth quarter valued at $64,291,000. Public Investment Fund acquired a new position in Claritev in the 2nd quarter valued at about $43,703,438. RBF Capital LLC grew its position in Claritev by 0.8% in the 1st quarter. RBF Capital LLC now owns 135,314 shares of the company's stock valued at $2,211,000 after acquiring an additional 1,127 shares in the last quarter. Bank of America Corp DE grew its position in Claritev by 146.6% in the 1st quarter. Bank of America Corp DE now owns 97,795 shares of the company's stock valued at $1,598,000 after acquiring an additional 58,133 shares in the last quarter. Finally, FAS Wealth Partners Inc. increased its stake in Claritev by 49.5% during the first quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company's stock worth $759,000 after purchasing an additional 15,380 shares during the period. 87.15% of the stock is currently owned by institutional investors and hedge funds.

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.